Formulation Development
Cellares & University of Wisconsin School of Medicine & Public Health Expand Partnership to Clinical Manufacturing of CRISPR-Edited CAR-T for Solid Tumors
Cellares and the University of Wisconsin (UW) School of Medicine and Public Health recently announced an expansion of their partnership to support clinical production and…
Affibody’s Licensee Announces Positive Data for Phase 1 Study Demonstrating Complete & Sustained Inhibition of Terminal Complement
Affibody’s licensee Rallybio Corporation (Rallybio) has announced positive results from its Phase 1 confirmatory pharmacokinetic/pharmacodynamic (PK/PD) clinical study evaluating RLYB116, an innovative, once-weekly, small volume,…
Axplora Announces Multi-Million Investment to Expand Lyophilization at Le Mans & Appoints New Head of Site
Axplora recently announced a multi-million-euro investment to expand lyophilization capabilities at its Le Mans site, strengthening its ability to deliver reliable, efficient and fast ADC…
Korsana Biosciences Emerges From Stealth With $175 Millon in Funding to Advance Potential Best-in-Class Therapeutics for Neurodegenerative Diseases
Korsana Biosciences, Inc. recently announced its emergence from stealth, with backing from a leading syndicate of healthcare investors. The Company was founded in 2024 with…
Axol Bioscience Acquires Ophthalmology Business From Newcells Biotech
Axol Bioscience Ltd. recently announced it has acquired the ophthalmology business of Newcells Biotech, a leading drug discovery partner specializing in the development of in…
Evogene & Queensland University of Technology Announce a Collaboration to Advance AI-Driven Cancer Therapeutics
Evogene Ltd. recently announced a collaboration with the pioneering research group of Dr. Mark Adams, a leading cancer genomics expert in the School of Biomedical…
Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics & $200 Million Concurrent Private Placement
Sensei Biotherapeutics, Inc. recently announced it has acquired Faeth Therapeutics Inc., a clinical-stage biotechnology company developing multi-node therapies that target tumor metabolism and signaling. The…
Nuclera & leadXpro Partner to Accelerate Structure-Based Drug Design for Complex Membrane Proteins
Nuclera and leadXpro recently announced a scientific partnership. The collaboration brings together eProtein Discovery’s rapid multiplex membrane protein screening with leadXpro’s AI/ML-driven construct design and…
Deciphera Pharmaceuticals Announces US FDA Acceptance for Filing of NDA for Tirabrutinib in Patients With Relapsed or Refractory PCNSL
Deciphera Pharmaceuticals recently announced the US FDA has accepted for filing the New Drug Application (NDA) under the accelerated approval pathway for tirabrutinib, a highly…
Cyrano Therapeutics Announces Positive Topline Results of a Proprietary & Potential First-to-Market Regenerative Therapy for Persistent Smell Loss
Cyrano Therapeutics, Inc. recently announced positive topline results from its Phase 2 FLAVOR trial of CYR-064, an innovative, intranasal soft-mist spray for the treatment of persistent…
Annovis Secures DSMB Approval to Advance Pivotal Phase 3 Trial of Buntanetap in Alzheimer’s Disease
Annovis Bio, Inc. recently announced an independent Data and Safety Monitoring Board (DSMB) has issued a positive recommendation regarding the safety of buntanetap at 6…
Rottendorf Pharma & Corealis Pharma Offer Seamless OSD Development & Manufacturing
Rottendorf Pharma and Corealis Pharma have expanded their service offering through a strategic partnership. The collaboration offers pharmaceutical and biotech companies a strategic transatlantic alliance…
Sirio Pharma to Introduce First-in-Market Lutein Soft Chew for Eye Health
Sirio Pharma has collaborated with prominent science-backed ingredient provider OmniActive Health Technologies (OmniActive) to launch a first-in-market soft chew lutein supplement. Featuring OmniActive’s award-winning Lutemax…
Thermo Fisher Scientific Expands Real-World Data Interoperability & Linkage Through Strategic Collaboration With Datavant
Thermo Fisher Scientific recently announced a strategic data collaboration with Datavant, the data collaboration platform trusted for healthcare, to make it easier for pharmaceutical and…
Calla Lily Clinical Care & Merck Announce Strategic Collaboration to Advance Intravaginal Drug Delivery Platform
Calla Lily Clinical Care and Merck have entered a strategic collaboration to support the continued development of Callavid®, a novel platform for intravaginal drug delivery.…
MIMETAS & Partners Launch World’s First Microphysiological Systems Industry Alliance
Today marks an important step for the global microphysiological systems (MPS) field with the launch of IAMPS – the Industry Alliance for Microphysiological Systems –…
Evogene Announces Expanded Collaboration With Google Cloud to Integrate AI Agents Into ChemPass AI
Evogene Ltd. recently announced an expanded phase of its collaboration with Google Cloud. Under this new phase, the collaboration will focus on developing and integrating…
Synthace Collaborates With Charles River to Offer Global Pharma Industry More Robust, Faster & Cost-Effective Assays
Synthace recently announced a collaboration with Charles River Laboratories International, Inc. Under the collaboration, Charles River will give its clients access to Synthace’s transformative approach to…
Sobi Completes Acquisition of Arthrosi Therapeutics, Strengthening Pipeline Potential Treatment of Gout
Swedish Orphan Biovitrum AB (publ) Sobi and Arthrosi Therapeutics, Inc. recently announced the completion of the acquisition of Arthrosi by Sobi. Upon completion of the…
Evinova & Bristol Myers Squibb Forge Strategic Collaboration to Optimize Clinical Development With Artificial Intelligence
Evinova recently announced Bristol Myers Squibb has signed an agreement to optimize clinical trials with Evinova’s AI-native clinical development platform. Under the terms of the…
